Moore
Laboratory

Molecular Neurodegeneration

The Moore Laboratory investigates the molecular pathophysiology of Parkinson’s disease, a chronic progressive neurodegenerative movement disorder. The majority of Parkinson’s disease cases occur in a sporadic manner although 5 to 10 % of cases are inherited, with causative mutations identified in at least eight genes. The Moore Laboratory studies the normal biology and pathobiology of gene products that cause inherited Parkinson’s disease, including the common leucine-rich repeat kinase 2 (LRRK2, PARK8), the retromer component VPS35 (PARK17), the E3 ubiquitin ligase parkin (PARK2), and the lysosomal P5-type ATPase ATP13A2 (PARK9).

The laboratory’s goal is to elucidate the normal biological function of these proteins in the mammalian brain and the molecular mechanism(s) through which disease-associated variants in these proteins induce neuronal dysfunction and eventual neurodegeneration in inherited forms of Parkinson’s disease. Through a clear understanding of the physiological function and pathological dysfunction of these proteins, the Moore Laboratory hopes to gain important insight into the molecular mechanisms and cellular pathways underlying neurodegeneration in inherited and idiopathic forms of Parkinson’s disease.

The laboratory adopts a translational approach to identify and validate novel therapeutic strategies that may slow or halt progressive neurodegeneration in Parkinson’s disease. To achieve these goals, the lab uses a multidisciplinary approach employing molecular, cellular and biochemical experimental techniques in a number of model systems including human cell lines, primary neuronal cultures, the baker’s yeast Saccharomyces cerevisiae, transgenic, knockout and viral-mediated gene transfer rodent models, and human brain tissue. The Moore Laboratory’s mission is to understand the molecular pathogenesis of Parkinson’s disease in order to develop novel targeted therapies and neuroprotective strategies to treat or prevent this devastating disease.

Join Our Team

We are continually seeking highly motivated individuals with a strong publication record to join our energetic and fast-paced lab as postdoctoral fellows. A Ph.D. with molecular and cellular biology or neuroscience experience is required to apply. Additional experience in biochemistry, proteomics, microscopy, viral vector technology, neuropathology and/or behavioral assays is preferred (but not necessary). Interested candidates should email Dr. Moore to inquire. Graduate students interested in joining the lab are encouraged to apply through Van Andel Institute Graduate School.

Contact Dr. Moore

Our Impact

We’re raising thousands to save millions.

We’re turning hope into action for the millions of people around the world affected by diseases like cancer and Parkinson’s. Find out how you can help us make a difference.

  • 141 peer-reviewed papers published in 2025, 74 of which were in high-impact journals
  • 15 VAI-SU2C Epigenetics Dream Team clinical trials launched to date
  • 10 clinical trials and related projects supported by VAI through the International Linked Clinical Trials Program

Darren Moore, Ph.D.

Chair and Professor, Department of Neurodegenerative Science; Director, MiND Program; Jay Van Andel Endowed Chair in Parkinson’s Disease Research

Areas of Expertise

Inherited Parkinson’s disease, LRRK2, VPS35, Parkin, ATP13A2, neurodegenerative disease models

Biography

Dr. Moore received a bachelor degree in molecular biology and genetics from the University of East Anglia in 1998 and his Ph.D. in molecular neuroscience from the University of Cambridge in 2001. He conducted postdoctoral research in the Department of Neurology and Udall Parkinson’s Disease Center of Excellence at the Johns Hopkins University School of Medicine. He later joined the Neurology faculty at Johns Hopkins in 2006 as assistant professor, before moving to the Brain Mind Institute of the Swiss Federal Institute of Technology (EPFL) in 2008. In 2014, Dr. Moore was recruited as an associate professor in the newly created Center for Neurodegenerative Science at Van Andel Institute, becoming full professor in 2017. In 2020, he was appointed as chair of the Department of Neurodegenerative Science and, in 2024, as the Jay Van Andel Endowed Chair in Parkinson’s Disease Research. His research focuses on understanding the cell biology and pathophysiological mechanisms underlying familial genes for Parkinson’s, including LRRK2, VPS35, α-synuclein and ATP13A2, and their contributions to the endolysosomal pathway.

Selected Publications

# Equal contributions * Co-corresponding authors

Alexis Bergsma, Ph.D.

Senior Lab Manager, Department of Neurodegenerative Science

Xi Chen, Ph.D.

Research Scientist, Department of Neurodegenerative Science

Ashley Douglass, B.S.

Senior Administrative Assistant II, Department of Neurodegenerative Science

Maxwell Frye

Ph.D. Student, VAI Graduate School

Research focus to be determined.

Vanessa Howland

Ph.D. Student, VAI Graduate School

Research Focus: Investigating genes associated with familial Parkinson's disease

Miguel Martinez

Ph.D. Student, VAI Graduate School

Research focus to be determined.

Brandon Meyerink, Ph.D.

Postdoctoral Fellow, Moore Laboratory

Jordan Rowlands, Ph.D.

Postdoctoral Fellow, Moore Laboratory

Kayla Sipple

Research Technician, Department of Neurodegenerative Science

Erin Williams, Ph.D.

Program Director, MiND

Lab Alumni

Theodor Brundin

Student Intern

Dylan Dues, Ph.D.

M.D.-Ph.D. Student

Valentin Cóppola-Segovia, Ph.D.

Postdoctoral Fellow

Lindsey Cunningham, Ph.D.

Van Andel Institute Graduate School Student

Madalynn Erb, Ph.D.

Research Scientist

Clarissa Ferolla, Ph.D.

Postdoctoral Fellow

Josue Gonzalez, Ph.D.

Postdoctoral Fellow

Gabriela Mercado Guerra, Ph.D.

Research Scientist

Md Shariful Islam, Ph.D.

Postdoctoral Fellow

Jen Kordich, M.S.

Laboratory Manager

Caroline Lee, Ph.D.

Postdoctoral Fellow

Nate Levine, B.S.

Research Associate

Allison Lindquist

Research Technician

Yue Ma, Ph.D.

Research Scientist

Emily Mace, B.S.

Administrative Assistant II

Caio Massari, Ph.D.

Postdoctoral Fellow

An Phu Tran Nguyen, Ph.D.

Research Scientist

Alina Offerman

Research Technician

Anthony Otero, Ph.D.

Postdoctoral Fellow

Kim Paquette

Laboratory Project Specialist I

Steve Pierce, Ph.D.

Computational Biologist III

Andrew Pyman

Assistant Research Technician

Dorian Sargent, Ph.D.

Research Scientist

Megan Senchuk, Ph.D.

Research Scientist

Lucas Stetzik, Ph.D.

Postdoctoral Fellow

JC van der Schans, B.S.

Lab Manager

Allie Weber

Van Andel Institute Graduate School Student

Kaitlyn Westra, B.S.

Computational Biologist I

Leslie Wyman, Ph.D.

Research Associate